Integrated Investment Consultants buys $257,803 stake in Core Laboratories N.V. (CLB)

Core Laboratories N.V. (CLB) : Integrated Investment Consultants scooped up 38 additional shares in Core Laboratories N.V. during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 14, 2016. The investment management firm now holds a total of 2,314 shares of Core Laboratories N.V. which is valued at $257,803.Core Laboratories N.V. makes up approximately 0.13% of Integrated Investment Consultants’s portfolio.

Other Hedge Funds, Including , Reliance Trust Co Of Delaware boosted its stake in CLB in the latest quarter, The investment management firm added 299 additional shares and now holds a total of 3,133 shares of Core Laboratories N.V. which is valued at $349,048. Core Laboratories N.V. makes up approx 0.03% of Reliance Trust Co Of Delaware’s portfolio.Howland Capital Management boosted its stake in CLB in the latest quarter, The investment management firm added 3,970 additional shares and now holds a total of 108,399 shares of Core Laboratories N.V. which is valued at $12,211,147. Core Laboratories N.V. makes up approx 1.16% of Howland Capital Management’s portfolio. Dynamic Advisors Solutions sold out all of its stake in CLB during the most recent quarter. The investment firm sold 2,010 shares of CLB which is valued $230,004. Chevy Chase Trust Holdings added CLB to its portfolio by purchasing 1,794 company shares during the most recent quarter which is valued at $200,695.

Core Laboratories N.V. closed down -1.24 points or -1.10% at $111.41 with 3,11,242 shares getting traded on Friday. Post opening the session at $113.11, the shares hit an intraday low of $110.52 and an intraday high of $113.58 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Core Laboratories N.V. reported $0.35 EPS for the quarter, based on the information available during the earnings call on Jul 20, 2016. Analyst had a consensus estimate of $0.35. The company had revenue of $148.10 million for the quarter, compared to analysts expectations of $146.21 million. The company’s revenue was down -27.4 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.81 EPS.

Investors should note that on Oct 11, 2016, Core Laboratories N.V. announced a cash dividend of $0.5500. The company’s management has announced Oct 19, 2016 as the ex-dividend date and fixed the record date on Oct 21, 2016. The payable date has been fixed on Nov 22, 2016.

Many Wall Street Analysts have commented on Core Laboratories N.V.. Credit Suisse Initiated Core Laboratories N.V. on Sep 1, 2016 to “Neutral”, Price Target of the shares are set at $115.

Core Laboratories N.V. (Core Lab) is a provider of proprietary and patented reservoir description production enhancement and reservoir management services to the oil and gas industry. These services and products are directed toward enabling its clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company operates in three segments: Reservoir Description Production Enhancement and Reservoir Management. The Company provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry.

Leave a Reply

Core Laboratories N.V. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Core Laboratories N.V.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.